Our Study Site ranked 6th in the world in recruiting patients to study 14-433 to evaluate the efficacy and safety of the drug ABT-494 in patients with Crohn's disease.
Study 14-433, sponsored by AbbVie: 6-th place in the world
- Super User
- Progress
- Read Time: 1 min
- Hits: 0
Our partners
